130 related articles for article (PubMed ID: 36650154)
1. Extending the data collection from a clinical trial: The Extended Salford Lung Study research cohort.
Meeraus W; Fu Q; Mu G; Fry M; Frith L; Pimenta JM
NPJ Prim Care Respir Med; 2023 Jan; 33(1):4. PubMed ID: 36650154
[TBL] [Abstract][Full Text] [Related]
2. Key Learnings from Running an Extension Study to a Real-World Effectiveness Trial: The Extended Salford Lung Study.
Meeraus W; Fry M; Yeatman R; Pimenta JM; Astrom J; Barth A; McCorkindale S; Jones R; Leather D
Adv Ther; 2021 Sep; 38(9):4847-4858. PubMed ID: 34357561
[TBL] [Abstract][Full Text] [Related]
3. Monitoring safety in a phase III real-world effectiveness trial: use of novel methodology in the Salford Lung Study.
Collier S; Harvey C; Brewster J; Bakerly ND; Elkhenini HF; Stanciu R; Williams C; Brereton J; New JP; McCrae J; McCorkindale S; Leather D
Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):344-352. PubMed ID: 27804174
[TBL] [Abstract][Full Text] [Related]
4. Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibility.
Elkhenini HF; Davis KJ; Stein ND; New JP; Delderfield MR; Gibson M; Vestbo J; Woodcock A; Bakerly ND
BMC Med Inform Decis Mak; 2015 Feb; 15():8. PubMed ID: 25880660
[TBL] [Abstract][Full Text] [Related]
5. Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes.
Doward L; Svedsater H; Whalley D; Crawford R; Leather D; Lay-Flurrie J; Bosanquet N
NPJ Prim Care Respir Med; 2017 Dec; 27(1):66. PubMed ID: 29247229
[TBL] [Abstract][Full Text] [Related]
6. Community pharmacy: a crucial enabler in creating the effectiveness study environment in the Salford Lung Studies.
Leather DA; Howard S; Haydock G; Stephens L
Int J Pharm Pract; 2020 Oct; 28(5):529-533. PubMed ID: 32589297
[TBL] [Abstract][Full Text] [Related]
7. The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials.
Albertson TE; Murin S; Sutter ME; Chenoweth JA
Pragmat Obs Res; 2017; 8():175-181. PubMed ID: 29033625
[TBL] [Abstract][Full Text] [Related]
8. Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups.
Bakerly ND; Woodcock A; Collier S; Leather DA; New JP; Crawford J; Harvey C; Vestbo J; Boucot I
Respir Med; 2019 Feb; 147():58-65. PubMed ID: 30704700
[TBL] [Abstract][Full Text] [Related]
9. A descriptive follow-up interview study assessing patient-centred outcomes: Salford Lung Study in Asthma (SLS Asthma).
Doward L; Svedsater H; Whalley D; Crawford R; Leather D; Lay-Flurrie J; Bosanquet N
NPJ Prim Care Respir Med; 2019 Aug; 29(1):31. PubMed ID: 31417102
[TBL] [Abstract][Full Text] [Related]
10. Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations.
Whalley D; Svedsater H; Doward L; Crawford R; Leather D; Lay-Flurrie J; Bosanquet N
NPJ Prim Care Respir Med; 2019 May; 29(1):20. PubMed ID: 31073124
[TBL] [Abstract][Full Text] [Related]
11. Obtaining real-world evidence: the Salford Lung Study.
New JP; Bakerly ND; Leather D; Woodcock A
Thorax; 2014 Dec; 69(12):1152-4. PubMed ID: 24603195
[TBL] [Abstract][Full Text] [Related]
12. Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data.
Sperrin M; Webb DJ; Patel P; Davis KJ; Collier S; Pate A; Leather DA; Pimenta JM
Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1369-1376. PubMed ID: 31385428
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness
Woodcock A; Boucot I; Leather DA; Crawford J; Collier S; Bakerly ND; Hilton E; Vestbo J
Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29467200
[TBL] [Abstract][Full Text] [Related]
14. Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect.
Pate A; Barrowman M; Webb D; Pimenta JM; Davis KJ; Williams R; Van Staa T; Sperrin M
BMJ Open Respir Res; 2018; 5(1):e000339. PubMed ID: 30397486
[TBL] [Abstract][Full Text] [Related]
15. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
[TBL] [Abstract][Full Text] [Related]
16. Patient and healthcare professional experiences of the Salford Lung Studies: qualitative insights for future effectiveness trials.
Gemzoe K; Crawford R; Caress A; McCorkindale S; Conroy R; Collier S; Doward L; Vekaria RM; Worsley S; Leather DA; Irving E
Trials; 2020 Sep; 21(1):798. PubMed ID: 32943093
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Janjua S; Fortescue R; Poole P
Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
[TBL] [Abstract][Full Text] [Related]
18. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
Gregoriano C; Dieterle T; Breitenstein AL; Dürr S; Baum A; Maier S; Arnet I; Hersberger KE; Leuppi JD
Respir Res; 2018 Dec; 19(1):237. PubMed ID: 30509268
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
